期刊文献+

黄芪甲苷对肿瘤坏死因子-α诱导的大鼠血管平滑肌细胞增殖、迁移的影响 被引量:7

Effects of Astragaloside IV on TNF-α-induced cell proliferation and migration in rat vascular smooth muscle cell
原文传递
导出
摘要 目的:研究黄芪甲苷(AS-IV)对肿瘤坏死因子(TNF-α)诱导的大鼠胸主动脉平滑肌细胞(A7r5细胞)增殖、迁移的影响。方法:建立体外TNF-α诱导的A7r5细胞增殖、迁移模型,用不同浓度AS-IV进行干预。应用WST-8法检测细胞增殖活性,用划痕实验和Transwell侵袭实验分别检测细胞迁移、侵袭能力。结果:A7r5细胞经TNF-α作用后,其增殖活性、迁移距离、侵袭能力均明显增加,与对照组相比有显著性差异(P<0.05);而经AS-IV干预后,细胞增殖活性降低、迁移距离变短、侵袭能力下降,与TNF-α组相比有显著性差异(P<0.05),并且这种药物抑制作用呈时间与剂量依赖性。结论:AS-IV可抑制TNF-α诱导的血管平滑肌细胞增殖、迁移,这可能是AS-IV预防和治疗血管再狭窄、动脉粥样硬化等血管增生性疾病的作用机制之一。 Objective:To investigate the effects of Astragaloside IV(AS-IV)on proliferation and migration of rat vascular smooth muscle cells from thoracic aorta(A7r5cells)that were induced by tumor necrosis factor-α(TNF-α).Method:The model of A7r5 cells proliferation and migration was established by TNF-αinducer in vitro,and intervened by different concentrations of AS-IV.A WST-8assay was used to evaluate cell proliferation activity.Wound migration assay and Transwell invasion assay were used to analyze cell migratory and invasive capability.Result:The proliferative activity,migratory distance and invasive capacity of A7r5 cells were obviously increased in the TNF-αgroup.There was a significant difference as compared with the control group(P〈0.05).But when pretreated with AS-IV ahead of time,the proliferative activity,migratory distance and invasive capacity of A7r5 cells were decreased in a time-and dose-dependent manner.There was a significant difference as compared with the TNF-αgroup(P〈0.05).Conclusion:AS-IV exerts inhibitory effects on vascular smooth muscle cells proliferation and migration,which may be one of the mechanisms that AS-IV can prevent and treat the vascular proliferative diseases such as reangiostenosis and atherosclerosis.
作者 牛珩 张金国
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2015年第10期1106-1111,共6页 Journal of Clinical Cardiology
基金 山东省自然科学基金项目(No:ZR2011HL006)
关键词 黄芪甲苷 A7r5细胞 肿瘤坏死因子-Α 增殖 迁移 Astragaloside IV A7r5cell tumor necrosis factor-α proliferation migration
  • 相关文献

参考文献16

  • 1LAMBERT L, BROWN K, SEGAL E, et al. Asso- ciation between timeliness of reperfusion therapy and clinical outcomes in ST-elevation myocardial infarction [J].JAMA, 2010, aoa, 2148-2155.
  • 2WEINTRAUB W S, SPERTUS J A, KOLM P, et al. Effect of PCI on quality of life in patients with sta- ble coronary disease [J]. N Engl J Med. 2008, 359: 677-687.
  • 3GASTERELL P J. Prevention of coronary restenosis [J]. Cardio-rev,1999, 7: 219-231.
  • 4BENNETT M R, O'SULLIVAN M. Mechanisms of angioplasty and stent restenosis: implications for de- sign of rational therapy [J]. Pharmacol Ther, 2001, 91:149-166.
  • 5INDOLFI C, MONGIARDO A, CURCIO A, et al. Molecular mechanisms of in-stent restenosis and ap- proach to therapy with eluting stents [J]. Trends Cardiovasc Med, 2003, 13 : 142 - 148.
  • 6HAO H, GABBIANI G, BOCHATON-PIALLAT M L. Arterial smooth muscle cell heterogeneity: impli- cations for atherosclerosis and restenosis development [J]. Arterioscler Thromb Vasc Biol, 2003, 23: 1510-1520.
  • 7段立军,孙博航.黄芪甲苷的研究进展[J].沈阳药科大学学报,2011,28(5):410-416. 被引量:138
  • 8CUTLIP D E, CHHABRA A G, BAlM D S, et al. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials [J]. Circula- tion, 2004,110:1226-1230.
  • 9LAFONT A, LIBBY P. The smooth muscle cell: sin- ner or saint in restenosis and the acute coronary syn- dromes? [J]. J Am Coll Cardiol, 1998, 32,283 - 285.
  • 10CAMPBELL G R, CAMPBELL J H. Smooth muscle phenotypic changes in arterial wall homeostasis: im- plications for the pathogenesis of atherosclerosis [J].Exp Mol Pathol, 1985,42:139-162.

二级参考文献42

共引文献887

同被引文献82

  • 1田琳,何春枝,李双杰.黄芪甲甙对病毒性心肌炎小鼠心肌中TL1A表达的影响及意义[J].中南大学学报(医学版),2015,40(2):150-157. 被引量:7
  • 2李惠红.小剂量黄芪升血压,大剂量黄芪降血压[J].中国中医药杂志,2004,2(5):272-273. 被引量:12
  • 3霍根红.黄芪心血管药理作用研究进展[J].河南中医学院学报,2007,22(1):86-88. 被引量:49
  • 4HU Qi, CHEN Jing, ZHANG Jing, et al. IOX1, a JMJD2A inhibitor, suppresses the proliferation and migration of vascu- lar smooth muscle cells induced by angiotensin II by regula- ting the expression of cell cycle-related proteins [J]. Int J Mol Med, 2016, 37(1): 189-196.
  • 5DAVIS D N. WU C, HATA A. micromanaging vascular smooth muscle cell differentiation and phenotypic modulation [J]. Arterioscler Thromb Vase Biol, 2011, 31 (11) : 2370- 2377.
  • 6SPIN J M, MAEGDEFESSEL L, TSAO P S. Vascular smooth muscle cell phenotypic plasticity: focus on chromatin remodelling[J]. CardiovascRes, 2012, 95(2): 147-155.
  • 7LAN Taohua, HUANG Xiongqing, TAN Hongmei. Vascu lar fibrosis in atheroselerosis [J]. Cardiovase Pathol, 2013, 22(5) : 401-407.
  • 8SHANKMAN L S, GOMEZ D, CHEREPANOVA O A, et al. KLF4 dependent phenotypic modulation of smooth muscle ceils has a key role in atherosclerotie plaque pathogenesis [J]. Nat Med, 2015, 21(6): 628-637.
  • 9GOMEZ D, OWENS G K. Smooth muscle cell phenotypic switching in atherosclerosis [J]. Cardiovasc Res, 2012, 95 (2) : 156-164.
  • 10MORROW D, GUHA S, SWEENEY C, et al. Notch and vascular smooth muscle cell phenotype [J]. Circ Res, 2008, 103(12) : 1370-1382.

引证文献7

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部